top of page


Product Name | Chemical Name | CAS Numbers |
---|---|---|
Lorlatinib | (alphaS)-5-Fluoro-2-iodo-alpha-methylbenzenemethanol | 1454847-96-1 |
Acalabrutinib | [4-[(Pyridin-2-yl)carbomoyl]pheny]boronic acid | 850568-25-1 |
Acalabrutinib | (S)-Benzyl 2-(8-amino-1-bromoimidazol [1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate | 1420478-88-1 |
Acalabrutinib | N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | 1383385-64-5 |
Acalabrutinib | 4-[8-Amino-3-(2S)-2-pyrrolidinylimidazol[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide | 1420478-90-5 |
Acalabrutinib | (2S)-2-[8-Amino-1-[4-[(2-pyridinylamino)carbonyl]phenyl]imidazol[1,5-a]purirazin-3-yl]-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1420478-89-2 |
Asciminib | (R)-N-(4-(chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1-((2-(trimethylsily)ethoxy)methyl)-1H-purazol-5-yl)nicotinamide | 1598430-18-2 |
Asciminib | (R)-5-bromo-N-(4-(chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)nicotimamide | 1491150-21-0 |
Asciminib | 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole | 903550-12-9 |
Alogliptin Benzoate | 6-Chloro-3-methylluracil | 4318-56-3 |
Alogliptin Benzoate | 2-[(6-Chloro-3,4-dihydro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-purorimidinyl)methyl)]benzonitrile | 865758-96-9 |
Apixaban | 3,3-Dichloro-1-(4nitrophenyl)-2-piperidinone | 881386-01-2 |
Apixaban | 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone | 536760-29-9 |
Apixaban | Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 |
Apixaban | 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-[uridin-2-one | 545445-44-1 |
Apixaban | 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 536759-91-8 |
Apixaban | 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyyridine-3-carboxylic acid ethyl ester | 503614-91-3 |
Apixaban | 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyyridine-3-carboxylic acid | 503614-92-4 |
Abrocitinib | (1s,3s)-N1-methyl-N1-(7H-pyrrolo[2,3-d]pjpyrimidin-4-yl)cyclobutane-1,3-diamine hydrogen chloride | 1622903-13-2 |
Abrocitinib | benzyl ((1s,3s)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)cyclobutyl)carbamate | 1622903-12-1 |
Brigtinib | 1-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine | 761440-65-7 |
Brigtinib | 2,5-Dichloro-N-[2-(dimethylphospiny)phenyl]-4-pyrimidinamine | 1197953-49-3 |
Baricitinib | 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile | 1187595-85-2 |
Baricitinib | 4-(1H-Pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine | 941685-27-4 |
Baloxavir Marboxil | 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol | 1985607-83-7 |
Baloxavir Marboxil | 3-Benzyloxy-4-oxo-4H-pyran-2-carboxylic acid | 119736-16-2 |
Baloxavir Marboxil | (12aR)-3,4,12,12a-Tetrahydro-7-)phenylmethoxy)-1h-[1,4]oxacino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | 1985607-70-2 |
Baloxavir Marboxil | Baloxavir | 1985605-59-1 |
Bepotastine Besilate | (S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine | 201594-84-5 |
Bepotastine Besilate | 2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine (2R,3R)-2,3-Dihydroxybutanedioate | 210095-58-2 |
Bepotastine Besilate | 2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine,N-acetyl-L-Phenylalanine(1:1) | 210095-66-2 |
Bepotastine Besilate | alpha-(4-chlorophenyl)pyridine-2-methanol | 27652-89-7 |
Bepotastine Besilate | 2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine | 122368-54-1 |
Bepotastine Besilate | Bepotastine Ethyl Ester | 190730-39-3 |
Crizotimib | 4-[4-[6-Amino-5-[[(R)-1-(2,6-dichloro-3-fluorophenyl)ethyl]oxy]pyridin-3-yl]piperidine-1-carboxylic acid tert-butyl ester | 877399-51-4 |
Crizotimib | [5-Bromo-3-[(1R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-yl]amine | 877399-00-3 |
Crizotimib | tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine1-1carboxylate | 877399-74-1 |
Carbozantinib D-malate | 1,1-Cyclopropanedicarboxylic acid monoethyl ester | 3697-66-3 |
Carbozantinib D-malate | 1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid | 849217-48-7 |
Carbozantinib D-malate | 4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline | 190728-25-7 |
Canaglifloxin Hemihydrate | 2-(4-Fluorophenyl)thiophene | 58861-48-6 |
Canaglifloxin Hemihydrate | 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide | 81058-27-7 |
Canaglifloxin Hemihydrate | 2-[(5-Bromo-2-mehylphenyl)methyl]-5-(4-fluorophenyl)thiophene | 1030825-20-7 |
Canaglifloxin Hemihydrate | 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiopene | 898566-17-1 |
Canaglifloxin Hemihydrate | (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate);Piv-Canaglifloxin | 1283129-18-9 |
Contract Media | Iohexol iodide | 76801-93-9 |
Contract Media | Iohexol hydrolysate | 31127-80-7 |
Contract Media | Ioversol hydrolysate | 77868-40-7 |
Dacomitinib | (2E)-4-(1-piperidinyl)-2-Butenoic acid hydrochloride | 197892-69-6 |
Dacomitinib | N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-Quinazolinamine | 162012-67-1 |
Dapaglifloxin Propanediol Monohydrate | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
Dapaglifloxin Propanediol Monohydrate | 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether | 461432-23-5 |
Dapaglifloxin Propanediol Monohydrate | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate | 461432-25-7 |
Dapaglifloxin Propanediol Monohydrate | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; Dapaglifloxin base | 461432-26-8 |
Diquafosol | Uridine 5'-monophosphate disodium salt(UMP-Na2) | 3387-36-8 |
Diquafosol | Uridine 5'-diphosphate disodium salt(UDP-Na2) | 27821-45-0 |
Diquafosol | Uridine 5'-triphosphate trisodium salt (UTP-Na3) | 19817-92-6 |
Deucravacitinib | 6-chloro-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide | 1609394-23-1 |
Deucravacitinib | 4,6-dichloro-N-(methyl-d3)pyridazine-3-carboxamide | 1609393-89-6 |
Deucravacitinib | 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline | 1609394-10-6 |
Empaglifloxin | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empaglifloxin | (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan | 915095-89-5 |
Empaglifloxin | (3S)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan | 915095-94-2 |
Empaglifloxin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
Empaglifloxin | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol tetraacetate | 915095-99-7 |
Ertuglifloxin L-pyroglutamic acid | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
Ertuglifloxin L-pyroglutamic acid | 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether | 461432-23-5 |
Ertuglifloxin L-pyroglutamic acid | Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]pheny;]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside | 1528636-39-6 |
Erguglifloxin L-pyroglutamic acid | 1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl)phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose; Ertuglifloxin base | 1210344-57-2 |
Elagolix Sodium | 5-Bromo-1-[2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione | 830346-48-0 |
Elagolix Sodium | 1-[[2-Fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methyl-2,4(1H,3H)-pyrimidinedione | 1150560-54-5 |
Elagolix Sodium | 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione | 1150560-59-0 |
Elagolix Sodium | 3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione | 830346-50-4 |
Elagolix Sodium | N-[2-Fluoro-6-(trifluoromethyl)benzyl]urea | 830346-46-8 |
Elagolix Sodium | 1-[2-Fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione | 830346-47-9 |
Favipiravir | 3,6-Dichloro-2-pyrazinecarbonitrile | 356783-16-9 |
Favipiravir | 6-Bromo-3-hydroxypyrazine-2-carboxamide | 259793-88-9 |
Favipiravir | 6-Fluoro-3-hydroxy-2-pyrazinecarbonitrile dicyclohemylamine salt | 1137606-74-6 |
Favipiravir | 2-Aminomalonamide | 62009-47-6 |
Favipiravir | Diethyl aminomalonate hydrochloride | 13433-00-6 |
Filgotinib Maleate | N-(5-(4-(bromomethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | 1206163-59-8 |
Filgotinib Maleate | N-(5-(4-(hydroxymethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | 1142936-49-9 |
Filgotinib Maleate | 5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine | 1257705-09-1 |
Ibrutinib | (S)-1-Boc-3-hydroxypiperidine | 143900-44-1 |
Ibrutinib | 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimi4din-4-amine | 330786-24-8 |
Ibrutinib | (R)-tert-Butyl 3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate (N-1) | 1022150-11-3 |
Ibrutinib | 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine | 1022150-12-4 |
Imeglimin Hydrochloride | N2,N2,6-trimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine hydrochloride | 352211-11-1 |
Lenvatinib Mesylate | 4-Amino-3-chlorophenol hydrochloride | 52671-64-4 |
Lenvatinib Mesylate | 4-Chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 |
Lenvatinib Mesylate | N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea | 796848-79-8 |
Larotrectinib Sulfate | (S)-3-Hydroxypyrrolidine hydrochloride | 122536-94-1 |
Larotrectinib Sulfate | (R)-2-(2,5-Difluorophenyl)pyrrolidine | 1218935-59-1 |
Larotrectinib Sulfate | (R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride | 1218935-60-4 |
Larotrectinib Sulfate | 5-Chloro-3-nitropyrazolo[1,5-a]pyrimidine | 1363380-51-1 |
Larotrectinib Sulfate | (2R)-2-hydroxy-Butanedioic acid compd.with (2R)-(2R)-2-92,5-difluorophenyl)pyrrolidine (1:1) | 1919868-77-1 |
Lorlatinib | methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate | 1454848-00-0 |
Lorlatinib | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)methyl)carbamate | 1454848-24-8 |
Lorlatinib | 1-Methyl-3-[(3methyllamino)methyl]-1H-pyrazole-5-carbonitrile hydrochloride (1:1) | 1643141-20-1 |
Linagliptin | 8-Bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione | 666816-98-4 |
Linagliptin | 2-(Chloromethyl)-4-methylquinazoline | 109113-72-6 |
Linagliptin | (R)-3-Aminopiperidine dihydrochloride | 334618-23-4 |
Linagliptin | 8-Bromo-7-(2-butynyl-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione | 853029-57-9 |
Lafutidine | 2-((furan-2-ylmethyl)sulfinyl)acetic acid | 146447-26-9 |
Lafutidine | 4-nitrophenyl 2-((furan-2-ylmethyl)sulfinyl)acetate | 123855-55-0 |
Molnupiravir | Hydroxylamine | 7803-49-8 |
Molnupiravir | 1,2,4-Triazole | 288-88-0 |
Molnupiravir | Uridine | 58-96-8 |
Molnupiravir | Cytidine | 65-46-3 |
Molnupiravir | ((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofiro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate | 2346620-54-8 |
Molnupiravir | ((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate | 2346620-55-9 |
Neratinib Maleate | trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 |
Neratinib Maleate | 2-Chloro-4-[(pyridin-2-yl)methyloxy]aniline | 524955-09-7 |
Neratinib Maleate | N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide | 848133-76-6 |
Neratinib Maleate | (2E)-N-[4-[[3-chloro-4-[(pyridin-2-ul)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide; Neratinib base | 698387-09-6 |
Niraparib Tosylate Monohydrate | 1H-Indazole -7- carboxylic acid | 677304-69-7 |
Niraparib Tosylate Monohydrate | (3S)-3-(4-Bromophenyl)-1-piperidinecarboxylic acid 1,1-dimethyllethyl ester | 1476776-55-2 |
Niraparib Tosylate Monohydrate | (3S)-3-(4-Aminophenyl)-1-piperidinecarboxylic acid 1,1-dimethyllethyl ester | 1171197-20-8 |
Niraparib Tosylate Monohydrate | Methyl3-formyl-2-nitrobenzoate | 138229-59-1 |
Nintedanib Esylate | Methyl 2-oxoindole -6-carboxylate | 14192-26-8 |
Nintedanib Esylate | Methyl (E)-3-(methyoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | 1168150-46-6 |
Nintedanib Esylate | N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide | 262368-30-9 |
Nintedanib Esylate | Nintedanib Base | 656247-17-5 |
Nirmatrelvir | (1R,2S,5S)-methyl 6,6-dimethyl -3-azabicyclo[3.1.0]hexane-2-carboxylate hydrochloride | 565456-77-1 |
Nirmatrelvir | (S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoic acid | 62965-35-9 |
Nirmatrelvir | methyl (1R,2S,5S)-3-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 394735-26-3 |
Nirmatrelvir | (1R,2S,5S)-3-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 394735-37-6 |
Nirmatrelvir | (S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanamide hydrochloride | 2628280-48-6 |
Nirmatrelvir | (S)-methyl-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate | 328086-60-8 |
Nirmatrelvir | 3-methyl-n-(trifluoroacetyl)-L-valine | 666832-71-9 |
Nirmatrelvir | (1R,5S)-6,6-Dimethyl-3-azabicylo[3.1.0]hexane | 943516-54-9 |
Osimertinib Mesylate | 4-Fluoro-2-methoxy-5-nitroaniline | 1075705-01-9 |
Osimertinib Mesylate | 3-(2-Chloro-4-pyrimidinyl)-1-methyl-1H-indole | 1032452-86-0 |
Osimertinib Mesylate | N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine | 1421372-94-2 |
Osimertinib Mesylate | N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1,4-benzenediamine | 1421372-67-9 |
Osimertinib Mesylate | N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine | 1421372-66-8 |
Palbociclib | 2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one | 1013916-37-4 |
Palbociclib | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1016636-76-2 |
Palbociclib | 4-(6-Aminopyridin-3-yl)piperazie-1-carboxylic acid tert-butyl ester | 571188-59-5 |
Palbociclib | 4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxyl acid tert-butyl ester | 866084-31-3 |
Ribociclib Succinate | 2-Chloro -7-cyclophenyl-N,N-dimethyl-7H-pyrrolo(2,3-d]pyrimidine-6-carboxamide | 1211443-61-6 |
Ribociclib Succinate | tert Butyl4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 |
Ribociclib Succinate | 7-Cyclopentyl-N,N-dimethyl-2[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide;Ribociclib base | 1211441-98-3 |
Relugolix | 4-Nitrophenylacetic acid | 104-03-0 |
Relugolix | Ethyl-2-amino-4-methyl-5-(4-nitro-phenyl)-thiophene-3-carboxylate | 174072-89-0 |
Relugolix | Ethyl-2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylic acid | 308831-94-9 |
Relugolix | 2-((2,6-Difluorobenzyl)(ethoxycarbonyl)amino-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid | 1589503-95-6 |
Relugolix | 3-Amino-6-methoxypyridazine | 7252-84-8 |
Relugolix | 2,6-Difluorobenzyl chloride | 697-73-4 |
Relugolix | 2,6-Difluorobenzyl bromide | 85118-00-9 |
Remdesivir | Pyrrolo[2-,1-f][1,2,4]triazin-4-amine | 159326-68-8 |
Remdesivir | 7-lodopyrrolo[2,1-f][1,2,4]triazin-4-amine | 1770840-43-1 |
Remdesivir | N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine-2-ethylbutyl ester | 1354823-36-1 |
Remdesivir | 2-C-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile | 1191237-69-0 |
Remdesivir | N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl)-L-alanine-2-ethylbutyl ester | 1911578-98-7 |
Remdesivir | 2-C-(4-aminopyrrolo[2,1-f][2,1,4]triazin-7-yl)-2,5-anhydro-3,4-O-(1-methylethylidene)-D-Altrononitrile | 1191237-80-5 |
Remdesivir | 2-Ethylbutyl (2S)-2-[[[3aR,4R,6R,6aR)-4-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-4-cyano-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxol-6-yl]methoxy-phenoxyphosphoryl]amino]propanoate | 1884576-18-4 |
Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
Rivaroxaban | 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone hydrochloride | 898543-06-1 |
Rivaroxaban | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
Rivaroxaban | (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 |
Rivaroxaban | 2-[(2-R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione | 446292-07-5 |
Rivaroxaban | 2-[[(5-S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione | 446292-08-6 |
Rimegepant Sulfate | (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol:dihydrochloride | 1373116-07-4 |
Rimegepant Sulfate | 7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | 39713-40-1 |
Rimegepant Sulfate | (R)-9-((triisopropylsily)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one hydrochloride | 1190363-45-1 |
Rimegepant Sulfate | 1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazol[4,5-b]pyridin-2(3H)-one | 1373116-06-3 |
Rimegepant Sulfate | (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methyllethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one | 1190363-46-2 |
Rimegepant Sulfate | 1-Bromo-2,3-dilfuorobenzene | 38573-88-5 |
Sunitinib Malate | 5-Fluoro-2-oxindole | 56341-41-4 |
Sunitinib Malate | N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-caboxamide | 356068-86-5 |
Sitagliptin Phosphate Monohydrate | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazinehydrochloride | 762240-92-6 |
Sitagliptin Phosphate Monohydrate | 2,4,5-Trifluorophenylacetic acid | 209995-38-0 |
Sitagliptin Phosphate Monohydrate | (2Z)-1-[3-Trifluoromethyl(-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butane-1,3-dione | 764667-65-4 |
Sitagliptin Phosphate Monohydrate | Sitagliptin base | 486460-32-6 |
Sotaglifloxin | ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone | 1103738-19-7 |
Sotaglifloxin | (2S,3S,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate | 1018899-03-0 |
Sacubitril+Valsartan(LCZ696) | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid | 1012341-50-2 |
Sacubitril+Valsartan(LCZ697) | (R)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbaMate | 1426129-50-1 |
Sacubitril+Valsartan(LCZ698) | (R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid | 1012341-48-8 |
Sacubitril+Valsartan(LCZ699) | (alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]alpha-methyl-[1,1'biphenyl]-4-pentanoic acid 4-ethyl ester acalcium salt (2:1) | 1369773-39-6 |
Sacubitril+Valsartan(LCZ700) | (2R,4s)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester;Sacubitril | 149709-62-6 |
Teneligliptin | (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester | 401564-36-1 |
Teneligliptin | 1-(3-Methyl-1-phenyl-5-pyrazoly)piperazine | 401566-79-8 |
Ticagrelor | 4,6-Dichloro-2-(propylthio)pyrimidin-5-amine | 145783-15-9 |
Ticagrelor | 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate | 376608-65-0 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | 2-[[(3aS,4R,6S,6aR)-4-[7-[[(1-R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol | 274693-26-4 |
Tegoprazan | 3,5-Difluorophenol | 2713-34-0 |
Tegoprazan | 2-Amino-3-nitrophenol | 603-85-0 |
Tegoprazan | (R)-5,7-difluorochroman-4-ol | 1270294-05-7 |
Tegoprazan | 2-methyl-7-phenylmethoxy-3H-Benzimidazole-5-carboxylic acid | 942195-83-7 |
Tegoprazan | 1-benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzol[d]imidazole-6-carboxamide | 1640981-20-9 |
Tegoprazan | 4-Hydroxy-2-methyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxylic acid | 1640981-19-6 |
Upadacitinib | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1428243-26-8 |
Upadacitinib | tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate | 1201187-44-1 |
Vildagliptin | L-Prolinamide | 7531-52-4 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrollidinecarbonitrile | 207557-35-5 |
Vildagliptin | 3-Amino-1-hydroxydamantane | 702-82-9 |
bottom of page